Unlicensed plasma product intended for further manufacture (into injectable or non-injectable products). Units of whole blood-derived FFP or PF24, if not needed for transfusion, may be re-labeled as recovered plasma and sold to manufacturers of plasma products. The “further manufacture” mentioned above includes preparation of multiple plasma derivatives such as albumin, intravenous immune globulin, and various coagulation factor concentrates. Recovered plasma is contrasted to “source plasma.”